TY - JOUR
T1 - Impact of pulse pressure variability evaluated by visit-to-visit on heart failure events in patients with hypertension
T2 - insights from the SPRINT trial
AU - Ma, Huan
AU - Wang, Minyan
AU - Qin, Chu
AU - Mandizadza, Oscar Onayi
AU - Wu, Li
AU - Cong, Ruichen
AU - Shi, Yun
AU - Mao, Wei
AU - Ji, Conghua
N1 - Publisher Copyright:
© 2024. The Author(s).
PY - 2024/11/24
Y1 - 2024/11/24
N2 - OBJECTIVES: In adult hypertensive patients, blood pressure variability is considered a risk factor for heart failure. The relationship between pulse pressure variability and the risk of heart failure remains unclear. This study aims to explore the impact of pulse pressure variability (PPV) on heart failure through a secondary analysis of the SPRINT randomized controlled trial. METHODS: The data were derived from the SPRINT (Systolic Blood Pressure Intervention Trial) study. The trial recruited participants 50 years or older, with SBP ≥ 130 mm Hg and at least one additional CVD risk factor. We calculated pulse pressure based on the systolic and diastolic blood pressure obtained during follow-up, and used the coefficient of variation to represent pulse pressure variability (PPV) for statistical analysis. We considered the incidence of acute decompensated heart failure as the outcome measure. We employed multivariable Cox regression analysis to examine the relationship between PPV and the risk of heart failure occurrence. Additionally, we used a restricted cubic spline model to analyze the dose-response relationship between PPV and the risk of heart failure occurrence. RESULTS: In this study, a total of 9429 participants were included. During a median follow-up time of 3.87 years, 188 new cases of heart failure were observed. The mean age of the study population was 67.9 ± 9.4 years and 3382 participants (35.5%) were females. The average PPCV was 13.85 ± 5.37%. The results from the multivariable Cox regression analysis indicated that the risk of heart failure increased by 3% for every 1% increase in PPCV (HR = 1.030 [95% CI 1.016-1.044]; P < 0.001). CONCLUSIONS: The study found that PPV is an independent risk factor for the occurrence of heart failure. This underscores the importance of maintaining long-term stability in pulse pressure, in preventing the development of heart failure.
AB - OBJECTIVES: In adult hypertensive patients, blood pressure variability is considered a risk factor for heart failure. The relationship between pulse pressure variability and the risk of heart failure remains unclear. This study aims to explore the impact of pulse pressure variability (PPV) on heart failure through a secondary analysis of the SPRINT randomized controlled trial. METHODS: The data were derived from the SPRINT (Systolic Blood Pressure Intervention Trial) study. The trial recruited participants 50 years or older, with SBP ≥ 130 mm Hg and at least one additional CVD risk factor. We calculated pulse pressure based on the systolic and diastolic blood pressure obtained during follow-up, and used the coefficient of variation to represent pulse pressure variability (PPV) for statistical analysis. We considered the incidence of acute decompensated heart failure as the outcome measure. We employed multivariable Cox regression analysis to examine the relationship between PPV and the risk of heart failure occurrence. Additionally, we used a restricted cubic spline model to analyze the dose-response relationship between PPV and the risk of heart failure occurrence. RESULTS: In this study, a total of 9429 participants were included. During a median follow-up time of 3.87 years, 188 new cases of heart failure were observed. The mean age of the study population was 67.9 ± 9.4 years and 3382 participants (35.5%) were females. The average PPCV was 13.85 ± 5.37%. The results from the multivariable Cox regression analysis indicated that the risk of heart failure increased by 3% for every 1% increase in PPCV (HR = 1.030 [95% CI 1.016-1.044]; P < 0.001). CONCLUSIONS: The study found that PPV is an independent risk factor for the occurrence of heart failure. This underscores the importance of maintaining long-term stability in pulse pressure, in preventing the development of heart failure.
KW - Coefficient
KW - Heart failure
KW - Hypertension
KW - Pulse pressure variability
KW - Risk prediction
UR - http://www.scopus.com/inward/record.url?scp=85210549431&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85210549431&partnerID=8YFLogxK
U2 - 10.1186/s40001-024-02164-0
DO - 10.1186/s40001-024-02164-0
M3 - Article
C2 - 39582008
AN - SCOPUS:85210549431
SN - 0949-2321
VL - 29
SP - 559
JO - European Journal of Medical Research
JF - European Journal of Medical Research
IS - 1
ER -